Literature DB >> 25532403

[Analysis of clinical effects of shuxuening injectionon renal function based on hospital information system data].

Jing Chen, Yan-Ming Xie, Wei Yang, Yong-Yan Wang, Li You, Yan Zhuang.   

Abstract

The safety of drugs has been the important issue that has caught the mutual attention of clinicians and patients. Kidney is one of the important organs in drug metabolism. The study is based on hospital information system (HIS) data from 20 nationwide general hospitals, indicated by Scr and BUN. Generalized boosted models (GBM) based on propensity score method were used to balance confounding factors. The study contrasts changes on renal function between used Shuxuening injection patients and the unused to explore whether Shuxuening injection affects renal function in clinical. The results showed that Shuxuening injection is likely to affect Scr in logistic regression (P value is 0.035); after the logistic regression based on propensity score method (P value became 0.513, 0.590), no differences were found between the two groups; before and after the logistic regression based on propensity score method (P value was less than 0.05), Shuxuening injection possibly affects BUN. Nevertheless, this study is a retrospective analysis. Logistic regression based on propensity score method can control the known confounding factors very well, while there may be the unknown ones. Therefore, the further exploration is required to monitor whether Shuxuening injection affects really BUN, which will provide clinical guidance for Shuxuening injection safe application.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25532403

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations.

Authors:  Can Wang; Qing-Ping Shi; Feng Ding; Xiao-Dong Jiang; Wei Tang; Mei-Ling Yu; Jian-Hua Zhu
Journal:  Drug Des Devel Ther       Date:  2018-04-05       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.